Anthem Reports Second Quarter 2017 Results
- Net income was $3.16 per share, including net negative adjustment items of $0.21 per share.
Adjusted net income was $3.37 per share (refer to the GAAP reconciliation table).
- Medical enrollment has increased by approximately 0.5 million members in 2017, or 1.2%, totaling
approximately 40.4 million members as of June 30, 2017.
- Company expects medical enrollment to grow by nearly 300 - 500 thousand members for the full year
2017.
- Full year 2017 GAAP net income is now expected to be greater than $10.35. Full year adjusted net
income is now expected to be greater than $11.70 (refer to the GAAP reconciliation table).
- Company increased its third quarter 2017 dividend to shareholders by $0.05 per share to $0.70 per
share.
Anthem, Inc. (NYSE: ANTM) today announced that second quarter 2017 net income was $855.3 million, or $3.16 per share. These
results included net negative adjustment items of $0.21 per share. Net income in the second quarter of 2016 was $780.6 million, or
$2.91 per share, which included net negative adjustment items of $0.42 per share.
Excluding the items noted in each period, adjusted net income was $3.37 per share in the second quarter of 2017 compared to the
adjusted net income of $3.33 per share in the prior year quarter (refer to the GAAP reconciliation table for the most directly
comparable measure calculated in accordance with U.S. generally accepted accounting principles, or “GAAP”).
“I am pleased with our second quarter 2017 results, carrying forward our operating momentum. Our commitment to improving the
quality and affordability of health care for our customers is resonating in the marketplace and benefiting our shareholders," said
Joseph Swedish, president and chief executive officer.
“Our solid second quarter financial results reflect solid performance across our various business segments, which is reflected
in our updated 2017 outlook,” said John Gallina, executive vice president and chief financial officer.
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled approximately 40.4 million members at June 30, 2017, an increase of 0.6
million members, or 1.6 percent, from 39.8 million at June 30, 2016. Commercial & Specialty Business enrollment increased
by 389 thousand medical members as the Company experienced growth in both fully insured and self-funded Local Group businesses,
partially offset by a decline in membership in the National Account and Individual businesses. Enrollment also grew by 193 thousand
in the Medicaid business and 58 thousand in the Medicare business.
Medical enrollment increased by 468 thousand during the first six months of 2017. Enrollment gains were primarily in the Local
Group, Individual, and Medicare businesses.
Operating Revenue: Operating revenue was $22.2 billion in the second quarter of 2017, an increase of $0.9 billion, or 4.3
percent, versus the $21.3 billion in the prior year quarter. The growth in revenue reflected premium rate increases to cover
overall cost trends across our business. Additionally, the increase was driven by higher enrollment in the Local Group insured and
self-funded businesses, as well as in Medicaid and Medicare. These increases were partially offset by the impact of the one year
waiver of the health insurance tax in 2017 and less favorable adjustments to the prior year risk adjustment estimates.
Benefit Expense Ratio: The benefit expense ratio was 86.1 percent in the second quarter of 2017, an increase of 190 basis
points from 84.2 percent in the prior year quarter. The increase, as expected, was largely driven by the impact of the one year
waiver of the health insurance tax in 2017 and less favorable adjustments to the prior year risk adjustment estimates. The increase
was partially offset by improved medical cost performance in the Local Group and Individual businesses.
Medical claims reserves established at December 31, 2016 developed moderately better than the Company’s expectation during the
first six months of 2017.
Medical Cost Trend: For the full year 2017, the Company continues to expect underlying Local Group medical cost trend to
be in the range of 6.5% - 7.0%.
Days in Claims Payable: Days in Claims Payable (“DCP”) was 40.5 days as of June 30, 2017, a decrease of 0.1 days
from 40.6 days as of March 31, 2017.
SG&A Expense Ratio: The SG&A expense ratio was 13.8 percent in the second quarter of 2017, a decrease of 20 basis
points from 14.0 percent in the second quarter of 2016. The decrease, as expected, was primarily driven by the impact of the one
year waiver of the health insurance tax in 2017, the impact of operating expense efficiency initiatives taken by the company, and
fixed cost leverage on operating revenue growth. The decrease was partially offset by higher performance-based incentive
compensation accruals and the 2015 cyber attack litigation settlement recorded during the quarter.
Operating Cash Flow: Operating cash flow was $393 million, or 0.5 times net income in the second quarter of 2017, and
approximately $3.1 billion, or 1.7 times net income for the first six months of 2017. The Company continues to expect its full year
2017 operating cash flow to be greater than $3.5 billion.
Share Repurchase Program: During the second quarter of 2017, the Company repurchased 2.5 million shares of its common
stock for $0.5 billion, or a weighted-average price of $182.83. During the first six months of 2017, the Company repurchased 2.8
million shares of its common stock for $0.5 billion, or a weighted average price of $180.37. As of June 30, 2017, the Company had
approximately $3.7 billion of Board-approved share repurchase authorization remaining.
Cash Dividend: During the second quarter of 2017, the Company paid a quarterly dividend of $0.65 per share, representing
a distribution of cash totaling $171.8 million.
On July 25, 2017, the Audit Committee declared a third quarter 2017 dividend to shareholders of $0.70 per share, an increase of
$0.05 per share from the second quarter dividend. On an annualized basis, this equates to a dividend of $2.80 per share. The third
quarter dividend is payable on September 25, 2017 to shareholders of record at the close of business on September 8, 2017.
Investment Portfolio & Capital Position: During the second quarter of 2017, the Company recorded net realized gains
on financial instruments totaling $16.2 million and other-than-temporary impairment losses totaling $7.2 million. During the second
quarter of 2016, the Company recorded net realized gains of $12.5 million and other-than-temporary impairment losses totaling $25.7
million.
As of June 30, 2017, the Company’s net unrealized gain position in the investment portfolio was $846.3 million, consisting
of net unrealized gains on equity and fixed maturity securities totaling $450.5 and $395.8 million, respectively. As of
June 30, 2017 cash and investments at the parent company totaled approximately $2.8 billion.
REPORTABLE SEGMENTS
Anthem, Inc. has three reportable segments: Commercial & Specialty Business (comprised of the Local Group, National
Accounts, Individual and Specialty businesses); Government Business (comprised of the Medicaid and Medicare businesses, National
Government Services, and the Federal Employee Program); and Other (comprised of unallocated corporate expenses and certain other
businesses that do not meet the quantitative thresholds for separate reportable segment disclosure).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anthem, Inc. |
|
Reportable Segment Highlights |
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
Three Months Ended June 30 |
|
Six Months Ended June 30 |
|
|
|
2017 |
|
2016 |
|
Change |
|
2017 |
|
2016 |
|
Change |
|
Operating Revenue |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Specialty Business |
|
$10,308.8 |
|
|
$9,898.3 |
|
|
4.1 |
% |
|
$20,598.4 |
|
|
$19,408.1 |
|
|
6.1 |
% |
|
Government Business |
|
11,883.4 |
|
|
11,371.1 |
|
|
4.5 |
% |
|
23,909.1 |
|
|
22,165.0 |
|
|
7.9 |
% |
|
Other |
|
5.8 |
|
|
5.1 |
|
|
13.7 |
% |
|
10.0 |
|
|
10.8 |
|
|
(7.4 |
)% |
|
Total Operating Revenue1 |
|
$22,198.0 |
|
|
$21,274.5 |
|
|
4.3 |
% |
|
$44,517.5 |
|
|
$41,583.9 |
|
|
7.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Gain / (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Specialty Business |
|
$967.9 |
|
|
$1,075.3 |
|
|
(10.0 |
)% |
|
$2,270.3 |
|
|
$2,368.3 |
|
|
(4.1 |
)% |
|
Government Business |
|
293.3 |
|
|
450.5 |
|
|
(34.9 |
)% |
|
611.9 |
|
|
775.5 |
|
|
(21.1 |
)% |
|
Other |
|
(34.2 |
) |
|
(25.6 |
) |
|
NM
|
2
|
|
(69.8 |
) |
|
(73.2 |
) |
|
NM
|
2
|
|
Total Operating Gain1 |
|
$1,227.0 |
|
|
$1,500.2 |
|
|
(18.2 |
)% |
|
$2,812.4 |
|
|
$3,070.6 |
|
|
(8.4 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Margin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Specialty Business |
|
9.4 |
% |
|
10.9 |
% |
|
(150)
|
bp
|
|
11.0 |
% |
|
12.2 |
% |
|
(120)
|
bp
|
|
Government Business |
|
2.5 |
% |
|
4.0 |
% |
|
(150)
|
bp
|
|
2.6 |
% |
|
3.5 |
% |
|
(90)
|
bp
|
|
Total Operating Margin1 |
|
5.5 |
% |
|
7.1 |
% |
|
(160)
|
bp
|
|
6.3 |
% |
|
7.4 |
% |
|
(110)
|
bp
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
See “Basis of Presentation.”
|
|
(2)
|
"NM" = calculation not meaningful.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Specialty Business: Operating gain in the Commercial & Specialty Business segment totaled $967.9
million in the second quarter of 2017, a decrease of $107.4 million, or 10.0 percent, from $1,075.3 million in the second quarter
of 2016. The decrease was driven by less favorable adjustments to the prior year risk adjustment estimates, the one year waiver of
the health insurance tax in 2017, and higher performance-based incentive compensation accruals. The decrease was partially offset
by improved medical cost performance in the Local Group and Individual businesses.
Government Business: Operating gain in the Government Business segment was $293.3 million in the second quarter of 2017,
a decrease of $157.2 million, or 34.9 percent, from $450.5 million in the second quarter of 2016. The decrease reflected higher
performance-based incentive compensation accruals and the impact of the one year waiver of the health insurance tax in 2017.
Other: The Company reported an operating loss of $34.2 million in the Other segment for the second quarter of 2017,
compared with an operating loss of $25.6 million in the prior year quarter.
OUTLOOK
Full Year 2017*:
- Net income is expected to be greater than $10.35 per share, including approximately $1.35 per share
of net unfavorable items. Excluding these items, adjusted net income is now expected to be greater than $11.70 (refer to the GAAP
reconciliation table).
- Medical membership is expected to be in the range of 40,200,000 - 40,400,000. Fully insured
membership is now expected to be in the range of 15,200,000 - 15,300,000 and self-funded membership is expected to be in the
range of 25,000,000 - 25,100,000.
- Operating revenue is now expected to be in the range of $88.5 - $89.5 billion.
- Benefit expense ratio is expected to be in the range of 87.0% plus or minus 30 basis points.
- SG&A ratio is expected to be in the range of 13.6% plus or minus 30 basis points.
- Operating cash flow is expected to be greater than $3.5 billion.
* This outlook includes the impact of the Penn Treaty assessments, 2015 cyber attack litigation settlement, and terminated
Cigna acquisition transaction costs incurred during the first half of 2017, but does not include any transaction or legal costs
associated with the terminated Cigna acquisition beyond those incurred in the first half of 2017.
Basis of Presentation
- Operating revenue and operating gain are the key measures used by management to evaluate performance
in each of its reporting segments, allocate resources, set incentive compensation targets and to forecast future operating
performance. Operating gain is calculated as total operating revenue less benefit expense and selling, general and administrative
expense. It does not include net investment income, net realized gains/losses on financial instruments, other-than-temporary
impairment losses recognized in income, interest expense, amortization of other intangible assets, gains/losses on extinguishment
of debt or income taxes, as these items are managed in a corporate shared service environment and are not the responsibility of
operating segment management (refer to the GAAP reconciliation tables).
- Operating margin is defined as operating gain divided by operating revenue.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m. Eastern Daylight Time (“EDT”) to discuss the company’s
second quarter results and outlook. The conference call should be accessed at least 15 minutes prior to the start of the call with
the following numbers:
| |
|
|
|
|
|
800-230-1092 (Domestic) |
|
|
|
|
|
800-475-6701 (Domestic Replay) |
|
|
|
|
|
|
612-288-0337 (International) |
|
|
|
|
|
320-365-3844 (International Replay) |
|
|
|
|
|
|
|
|
|
|
|
|
|
An access code is not required for today’s conference call. The access code for the replay is 403156. The replay will be
available from 11:00 a.m. EDT today, until the end of the day on August 9, 2017. The call will also be available through a live
webcast at www.antheminc.com under the “Investors” link. A webcast replay will be available
following the call.
About Anthem, Inc.
Anthem is working to transform health care with trusted and caring solutions. Our health plan companies deliver quality products
and services that give their members access to the care they need. With over 74 million people served by its affiliated companies,
including more than 40 million enrolled in its family of health plans, Anthem is one of the nation’s leading health benefits
companies. For more information about Anthem’s family of companies, please visit www.antheminc.com/companies.
| Anthem, Inc. |
| Membership Summary |
| (Unaudited and in Thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change from |
|
|
June 30, |
|
June 30, |
|
December 31, |
|
June 30, |
|
December 31, |
|
Medical Membership
|
|
2017 |
|
2016 |
|
2016 |
|
2016 |
|
2016 |
| Customer Type |
|
|
|
|
|
|
|
|
|
|
| Local Group |
|
15,705 |
|
|
15,192 |
|
|
15,429 |
|
|
3.4 |
% |
|
1.8 |
% |
| Individual |
|
1,779 |
|
|
1,812 |
|
|
1,664 |
|
|
(1.8 |
)% |
|
6.9 |
% |
|
|
|
|
|
|
|
|
|
|
|
| National: |
|
|
|
|
|
|
|
|
|
|
| National Accounts |
|
7,760 |
|
|
7,808 |
|
|
7,741 |
|
|
(0.6 |
)% |
|
0.2 |
% |
| BlueCard® |
|
5,561 |
|
|
5,604 |
|
|
5,550 |
|
|
(0.8 |
)% |
|
0.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
| Total National |
|
13,321 |
|
|
13,412 |
|
|
13,291 |
|
|
(0.7 |
)% |
|
0.2 |
% |
| Medicare |
|
1,484 |
|
|
1,426 |
|
|
1,438 |
|
|
4.1 |
% |
|
3.2 |
% |
| Medicaid |
|
6,529 |
|
|
6,336 |
|
|
6,527 |
|
|
3.0 |
% |
|
— |
% |
| FEP |
|
1,569 |
|
|
1,572 |
|
|
1,570 |
|
|
(0.2 |
)% |
|
(0.1 |
)% |
| Total Medical Membership |
|
40,387 |
|
|
39,750 |
|
|
39,919 |
|
|
1.6 |
% |
|
1.2 |
% |
| Funding Arrangement |
|
|
|
|
|
|
|
|
|
|
| Self-Funded |
|
24,938 |
|
|
24,550 |
|
|
24,688 |
|
|
1.6 |
% |
|
1.0 |
% |
| Fully-Insured |
|
15,449 |
|
|
15,200 |
|
|
15,231 |
|
|
1.6 |
% |
|
1.4 |
% |
| Total Medical Membership |
|
40,387 |
|
|
39,750 |
|
|
39,919 |
|
|
1.6 |
% |
|
1.2 |
% |
| Reportable Segment |
|
|
|
|
|
|
|
|
|
|
| Commercial and Specialty Business |
|
30,805 |
|
|
30,416 |
|
|
30,384 |
|
|
1.3 |
% |
|
1.4 |
% |
| Government Business |
|
9,582 |
|
|
9,334 |
|
|
9,535 |
|
|
2.7 |
% |
|
0.5 |
% |
| Total Medical Membership |
|
40,387 |
|
|
39,750 |
|
|
39,919 |
|
|
1.6 |
% |
|
1.2 |
% |
|
Other Membership
|
|
|
|
|
|
|
|
|
|
|
| Life and Disability Members |
|
4,705 |
|
|
4,689 |
|
|
4,732 |
|
|
0.3 |
% |
|
(0.6 |
)% |
| Dental Members |
|
5,818 |
|
|
5,413 |
|
|
5,486 |
|
|
7.5 |
% |
|
6.1 |
% |
| Dental Administration Members |
|
5,335 |
|
|
5,369 |
|
|
5,294 |
|
|
(0.6 |
)% |
|
0.8 |
% |
| Vision Members |
|
6,791 |
|
|
5,929 |
|
|
6,388 |
|
|
14.5 |
% |
|
6.3 |
% |
| Medicare Advantage Part D Members |
|
679 |
|
|
608 |
|
|
629 |
|
|
11.7 |
% |
|
7.9 |
% |
| Medicare Part D Standalone Members |
|
322 |
|
|
352 |
|
|
350 |
|
|
(8.5 |
)% |
|
(8.0 |
)% |
| |
| Anthem, Inc. |
| Consolidated Statements of Income |
| (Unaudited) |
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
| (In millions, except per share data) |
|
June 30 |
|
|
|
|
2017 |
|
2016 |
|
Change |
| Revenues |
|
|
|
|
|
|
| Premiums |
|
$ |
20,813.1 |
|
|
$ |
19,948.0 |
|
|
4.3 |
% |
| Administrative fees |
|
1,378.9 |
|
|
1,315.8 |
|
|
4.8 |
% |
| Other revenue |
|
6.0 |
|
|
10.7 |
|
|
(43.9 |
)% |
| Total operating revenue |
|
22,198.0 |
|
|
21,274.5 |
|
|
4.3 |
% |
| Net investment income |
|
200.2 |
|
|
194.9 |
|
|
2.7 |
% |
| Net realized gains on financial instruments |
|
16.2 |
|
|
12.5 |
|
|
29.6 |
% |
| Other-than-temporary impairment losses on investments: |
|
|
|
|
|
|
| Total other-than-temporary impairment losses on investments |
|
(7.3 |
) |
|
(33.8 |
) |
|
(78.4 |
)% |
| Portion of other-than-temporary impairment losses recognized in other
comprehensive income |
|
0.1 |
|
|
8.1 |
|
|
(98.8 |
)% |
| Other-than-temporary impairment losses recognized in income |
|
(7.2 |
) |
|
(25.7 |
) |
|
(72.0 |
)% |
|
|
|
|
|
|
|
| Total revenues |
|
22,407.2 |
|
|
21,456.2 |
|
|
4.4 |
% |
|
|
|
|
|
|
|
| Expenses |
|
|
|
|
|
|
| Benefit expense |
|
17,917.2 |
|
|
16,805.2 |
|
|
6.6 |
% |
| Selling, general and administrative expense: |
|
|
|
|
|
|
| Selling expense |
|
345.5 |
|
|
351.5 |
|
|
(1.7 |
)% |
| General and administrative expense |
|
2,708.3 |
|
|
2,617.6 |
|
|
3.5 |
% |
| Total selling, general and administrative expense |
|
3,053.8 |
|
|
2,969.1 |
|
|
2.9 |
% |
| Interest expense |
|
189.9 |
|
|
185.7 |
|
|
2.3 |
% |
| Amortization of other intangible assets |
|
40.6 |
|
|
47.9 |
|
|
(15.2 |
)% |
|
|
|
|
|
|
|
| Total expenses |
|
21,201.5 |
|
|
20,007.9 |
|
|
6.0 |
% |
|
|
|
|
|
|
|
| Income before income tax expense |
|
1,205.7 |
|
|
1,448.3 |
|
|
(16.8 |
)% |
|
|
|
|
|
|
|
| Income tax expense |
|
350.4 |
|
|
667.7 |
|
|
(47.5 |
)% |
|
|
|
|
|
|
|
| Net income |
|
$ |
855.3 |
|
|
$ |
780.6 |
|
|
9.6 |
% |
|
|
|
|
|
|
|
| Net income per diluted share |
|
$ |
3.16 |
|
|
$ |
2.91 |
|
|
8.6 |
% |
|
|
|
|
|
|
|
| Diluted shares |
|
270.8 |
|
|
268.2 |
|
|
1.0 |
% |
|
|
|
|
|
|
|
| Benefit expense as a percentage of premiums |
|
86.1 |
% |
|
84.2 |
% |
|
190bp |
| Selling, general and administrative expense as a percentage of total operating
revenue |
|
13.8 |
% |
|
14.0 |
% |
|
(20)bp |
| Income before income taxes as a percentage of total revenue |
|
5.4 |
% |
|
6.8 |
% |
|
(140)bp |
| |
| Anthem, Inc. |
| Consolidated Statements of Income |
| (Unaudited) |
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
| (In millions, except per share data) |
|
June 30 |
|
|
|
|
2017 |
|
2016 |
|
Change |
| Revenues |
|
|
|
|
|
|
| Premiums |
|
$ |
41,764.4 |
|
|
$ |
38,936.9 |
|
|
7.3 |
% |
| Administrative fees |
|
2,742.1 |
|
|
2,626.8 |
|
|
4.4 |
% |
| Other revenue |
|
11.0 |
|
|
20.2 |
|
|
(45.5 |
)% |
| Total operating revenue |
|
44,517.5 |
|
|
41,583.9 |
|
|
7.1 |
% |
| Net investment income |
|
407.4 |
|
|
366.0 |
|
|
11.3 |
% |
| Net realized gains (losses) on financial instruments |
|
23.5 |
|
|
(112.6 |
) |
|
(120.9 |
)% |
| Other-than-temporary impairment losses on investments: |
|
|
|
|
|
|
| Total other-than-temporary impairment losses on investments |
|
(16.9 |
) |
|
(119.0 |
) |
|
(85.8 |
)% |
| Portion of other-than-temporary impairment losses recognized in other
comprehensive income |
|
1.6 |
|
|
26.4 |
|
|
(93.9 |
)% |
| Other-than-temporary impairment losses recognized in income |
|
(15.3 |
) |
|
(92.6 |
) |
|
(83.5 |
)% |
|
|
|
|
|
|
|
| Total revenues |
|
44,933.1 |
|
|
41,744.7 |
|
|
7.6 |
% |
|
|
|
|
|
|
|
| Expenses |
|
|
|
|
|
|
| Benefit expense |
|
35,460.0 |
|
|
32,344.0 |
|
|
9.6 |
% |
| Selling, general and administrative expense: |
|
|
|
|
|
|
| Selling expense |
|
694.1 |
|
|
701.4 |
|
|
(1.0 |
)% |
| General and administrative expense |
|
5,551.0 |
|
|
5,467.9 |
|
|
1.5 |
% |
| Total selling, general and administrative expense |
|
6,245.1 |
|
|
6,169.3 |
|
|
1.2 |
% |
| Interest expense |
|
424.9 |
|
|
372.8 |
|
|
14.0 |
% |
| Amortization of other intangible assets |
|
82.4 |
|
|
98.3 |
|
|
(16.2 |
)% |
|
|
|
|
|
|
|
| Total expenses |
|
42,212.4 |
|
|
38,984.4 |
|
|
8.3 |
% |
|
|
|
|
|
|
|
| Income before income tax expense |
|
2,720.7 |
|
|
2,760.3 |
|
|
(1.4 |
)% |
|
|
|
|
|
|
|
| Income tax expense |
|
855.5 |
|
|
1,276.7 |
|
|
(33.0 |
)% |
|
|
|
|
|
|
|
| Net income |
|
$ |
1,865.2 |
|
|
$ |
1,483.6 |
|
|
25.7 |
% |
|
|
|
|
|
|
|
| Net income per diluted share |
|
$ |
6.89 |
|
|
$ |
5.54 |
|
|
24.4 |
% |
|
|
|
|
|
|
|
| Diluted shares |
|
270.6 |
|
|
267.8 |
|
|
1.0 |
% |
|
|
|
|
|
|
|
| Benefit expense as a percentage of premiums |
|
84.9 |
% |
|
83.1 |
% |
|
180bp |
| Selling, general and administrative expense as a percentage of total operating
revenue |
|
14.0 |
% |
|
14.8 |
% |
|
(80)bp |
| Income before income taxes as a percentage of total revenue |
|
6.1 |
% |
|
6.6 |
% |
|
(50)bp |
| |
| Anthem, Inc. |
| Consolidated Balance Sheets |
| |
|
|
June 30, |
|
December 31, |
| (In millions) |
|
2017 |
|
2016 |
| Assets |
|
(Unaudited) |
|
|
| Current assets: |
|
|
|
|
| Cash and cash equivalents |
|
$ |
4,561.2 |
|
|
$ |
4,075.3 |
|
| Investments available-for-sale, at fair value: |
|
|
|
|
| Fixed maturity securities |
|
18,948.2 |
|
|
17,163.1 |
|
| Equity securities |
|
1,823.8 |
|
|
1,468.5 |
|
| Other invested assets, current |
|
19.1 |
|
|
15.8 |
|
| Accrued investment income |
|
158.2 |
|
|
164.5 |
|
| Premium and self-funded receivables |
|
6,105.7 |
|
|
5,860.8 |
|
| Other receivables |
|
2,525.4 |
|
|
2,536.6 |
|
| Income taxes receivable |
|
— |
|
|
168.7 |
|
| Securities lending collateral |
|
1,214.5 |
|
|
1,079.8 |
|
| Other current assets |
|
1,774.6 |
|
|
1,781.8 |
|
| Total current assets |
|
37,130.7 |
|
|
34,314.9 |
|
|
|
|
|
|
| Long-term investments available-for-sale, at fair value: |
|
|
|
|
| Fixed maturity securities |
|
524.8 |
|
|
524.4 |
|
| Equity securities |
|
32.3 |
|
|
31.4 |
|
| Other invested assets, long-term |
|
2,352.1 |
|
|
2,240.5 |
|
| Property and equipment, net |
|
1,975.7 |
|
|
1,977.9 |
|
| Goodwill |
|
17,561.2 |
|
|
17,561.2 |
|
| Other intangible assets |
|
7,882.4 |
|
|
7,964.9 |
|
| Other noncurrent assets |
|
778.4 |
|
|
467.9 |
|
| Total assets |
|
$ |
68,237.6 |
|
|
$ |
65,083.1 |
|
|
|
|
|
|
| Liabilities and shareholders’ equity |
|
|
|
|
| Liabilities |
|
|
|
|
| Current liabilities: |
|
|
|
|
| Policy liabilities: |
|
|
|
|
| Medical claims payable |
|
$ |
7,969.5 |
|
|
$ |
7,892.6 |
|
| Reserves for future policy benefits |
|
69.6 |
|
|
71.8 |
|
| Other policyholder liabilities |
|
2,447.5 |
|
|
2,221.1 |
|
| Total policy liabilities |
|
10,486.6 |
|
|
10,185.5 |
|
| Unearned income |
|
1,837.8 |
|
|
971.9 |
|
| Accounts payable and accrued expenses |
|
3,815.7 |
|
|
4,014.9 |
|
| Income taxes payable |
|
113.0 |
|
|
— |
|
| Security trades pending payable |
|
227.8 |
|
|
93.5 |
|
| Securities lending payable |
|
1,213.7 |
|
|
1,078.9 |
|
| Short-term borrowings |
|
580.0 |
|
|
440.0 |
|
| Current portion of long-term debt |
|
624.4 |
|
|
928.4 |
|
| Other current liabilities |
|
3,668.9 |
|
|
3,581.3 |
|
| Total current liabilities |
|
22,567.9 |
|
|
21,294.4 |
|
|
|
|
|
|
| Long-term debt, less current portion |
|
15,088.0 |
|
|
14,358.5 |
|
| Reserves for future policy benefits, noncurrent |
|
619.0 |
|
|
666.1 |
|
| Deferred tax liabilities, net |
|
2,632.7 |
|
|
2,779.9 |
|
| Other noncurrent liabilities |
|
898.3 |
|
|
883.8 |
|
| Total liabilities |
|
41,805.9 |
|
|
39,982.7 |
|
|
|
|
|
|
| Shareholders’ equity |
|
|
|
|
| Common stock |
|
2.6 |
|
|
2.6 |
|
| Additional paid-in capital |
|
8,897.0 |
|
|
8,805.1 |
|
| Retained earnings |
|
17,667.0 |
|
|
16,560.6 |
|
| Accumulated other comprehensive loss |
|
(134.9 |
) |
|
(267.9 |
) |
| Total shareholders’ equity |
|
26,431.7 |
|
|
25,100.4 |
|
| Total liabilities and shareholders’ equity |
|
$ |
68,237.6 |
|
|
$ |
65,083.1 |
|
| |
| Anthem, Inc. |
| Consolidated Statements of Cash Flows |
| (Unaudited) |
|
|
|
|
|
| (In millions) |
|
Six Months Ended June 30 |
|
|
2017 |
|
2016 |
| Operating activities |
|
|
|
|
| Net income |
|
$1,865.2 |
|
$1,483.6 |
| Adjustments to reconcile net income to net cash provided by operating
activities: |
|
|
|
|
| Net realized (gains) losses on financial instruments |
|
(23.5 |
) |
|
112.6 |
|
| Other-than-temporary impairment losses recognized in income |
|
15.3 |
|
|
92.6 |
|
| Loss on disposal of assets |
|
0.4 |
|
|
0.6 |
|
| Deferred income taxes |
|
(209.9 |
) |
|
99.7 |
|
| Amortization, net of accretion |
|
385.0 |
|
|
399.4 |
|
| Depreciation expense |
|
54.5 |
|
|
51.7 |
|
| Share-based compensation |
|
87.1 |
|
|
82.4 |
|
| Excess tax benefits from share-based compensation |
|
— |
|
|
(46.0 |
) |
| Changes in operating assets and liabilities: |
|
|
|
|
| Receivables, net |
|
(134.7 |
) |
|
(332.8 |
) |
| Other invested assets |
|
(22.4 |
) |
|
(13.2 |
) |
| Other assets |
|
(322.4 |
) |
|
(284.5 |
) |
| Policy liabilities |
|
254.0 |
|
|
54.1 |
|
| Unearned income |
|
865.9 |
|
|
(312.7 |
) |
| Accounts payable and accrued expenses |
|
(53.0 |
) |
|
343.1 |
|
| Other liabilities |
|
81.5 |
|
|
(17.1 |
) |
| Income taxes |
|
281.7 |
|
|
338.2 |
|
| Other, net |
|
(43.4 |
) |
|
(22.3 |
) |
| Net cash provided by operating activities |
|
3,081.3 |
|
|
2,029.4 |
|
|
|
|
|
|
| Investing activities |
|
|
|
|
| Purchases of fixed maturity securities |
|
(7,637.0 |
) |
|
(5,509.3 |
) |
| Proceeds from sales and maturities of fixed maturity securities |
|
6,119.3 |
|
|
4,836.8 |
|
| Purchases of equity securities |
|
(506.0 |
) |
|
(1,032.3 |
) |
| Proceeds from sales of equity securities |
|
214.7 |
|
|
486.4 |
|
| Purchases of other invested assets |
|
(162.3 |
) |
|
(261.1 |
) |
| Proceeds from sales of other invested assets |
|
121.8 |
|
|
219.4 |
|
| Change in collateral and settlements of non-hedging derivatives |
|
(2.1 |
) |
|
14.7 |
|
| Changes in securities lending collateral |
|
(134.8 |
) |
|
(211.2 |
) |
| Net purchases of property and equipment |
|
(294.2 |
) |
|
(251.2 |
) |
| Other, net |
|
11.8 |
|
|
— |
|
| Net cash used in investing activities |
|
(2,268.8 |
) |
|
(1,707.8 |
) |
|
|
|
|
|
| Financing activities |
|
|
|
|
| Net proceeds from/(repayments of) commercial paper borrowings |
|
1,347.8 |
|
|
(225.2 |
) |
| Net proceeds from/(repayments of) short-term borrowings |
|
140.0 |
|
|
(100.0 |
) |
| Net repayments of long-term borrowings |
|
(929.9 |
) |
|
— |
|
| Changes in securities lending payable |
|
134.8 |
|
|
211.1 |
|
| Changes in bank overdrafts |
|
(146.2 |
) |
|
15.2 |
|
| Repurchase and retirement of common stock |
|
(509.0 |
) |
|
— |
|
| Change in collateral and settlements of debt-related derivatives |
|
(128.4 |
) |
|
(467.5 |
) |
| Cash dividends |
|
(344.0 |
) |
|
(341.6 |
) |
| Proceeds from issuance of common stock under employee stock plans |
|
151.0 |
|
|
71.7 |
|
| Taxes paid through withholding of common stock under employee stock plans |
|
(45.6 |
) |
|
(63.1 |
) |
| Excess tax benefits from share-based compensation |
|
— |
|
|
46.0 |
|
| Net cash used in financing activities |
|
(329.5 |
) |
|
(853.4 |
) |
|
|
|
|
|
| Effect of foreign exchange rates on cash and cash equivalents |
|
2.9 |
|
|
1.0 |
|
|
|
|
|
|
| Change in cash and cash equivalents |
|
485.9 |
|
|
(530.8 |
) |
| Cash and cash equivalents at beginning of year |
|
4,075.3 |
|
|
2,113.5 |
|
|
|
|
|
|
| Cash and cash equivalents at end of period |
|
$4,561.2 |
|
$1,582.7 |
| |
| Anthem, Inc. |
| Reconciliation of Medical Claims Payable |
| |
|
|
Six Months Ended |
|
|
|
|
June 30 |
|
Years Ended December 31 |
|
|
2017 |
|
2016 |
|
2016 |
|
2015 |
|
2014 |
| (In millions) |
|
(Unaudited) |
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross medical claims payable, beginning of period |
|
$ |
7,892.6 |
|
|
$ |
7,569.8 |
|
|
$ |
7,569.8 |
|
|
$ |
6,861.2 |
|
|
$ |
6,127.2 |
|
| Ceded medical claims payable, beginning of period |
|
(539.1 |
) |
|
(645.6 |
) |
|
(645.6 |
) |
|
(767.4 |
) |
|
(23.4 |
) |
| Net medical claims payable, beginning of period |
|
7,353.5 |
|
|
6,924.2 |
|
|
6,924.2 |
|
|
6,093.8 |
|
|
6,103.8 |
|
|
|
|
|
|
|
|
|
|
|
|
| Business combinations and purchase adjustments |
|
— |
|
|
— |
|
|
— |
|
|
121.8 |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
| Net incurred medical claims: |
|
|
|
|
|
|
|
|
|
|
| Current year |
|
35,686.5 |
|
|
32,452.2 |
|
|
66,371.4 |
|
|
60,708.4 |
|
|
56,305.8 |
|
| Prior years redundancies(1) |
|
(951.0 |
) |
|
(726.3 |
) |
|
(850.4 |
) |
|
(800.2 |
) |
|
(541.9 |
) |
| Total net incurred medical claims |
|
34,735.5 |
|
|
31,725.9 |
|
|
65,521.0 |
|
|
59,908.2 |
|
|
55,763.9 |
|
|
|
|
|
|
|
|
|
|
|
|
| Net payments attributable to: |
|
|
|
|
|
|
|
|
|
|
| Current year medical claims |
|
28,540.4 |
|
|
26,197.1 |
|
|
59,156.6 |
|
|
54,067.7 |
|
|
50,353.9 |
|
| Prior years medical claims |
|
6,070.9 |
|
|
5,541.4 |
|
|
5,935.1 |
|
|
5,131.9 |
|
|
5,420.0 |
|
| Total net payments |
|
34,611.3 |
|
|
31,738.5 |
|
|
65,091.7 |
|
|
59,199.6 |
|
|
55,773.9 |
|
|
|
|
|
|
|
|
|
|
|
|
| Net medical claims payable, end of period |
|
7,477.7 |
|
|
6,911.6 |
|
|
7,353.5 |
|
|
6,924.2 |
|
|
6,093.8 |
|
| Ceded medical claims payable, end of period |
|
491.8 |
|
|
587.0 |
|
|
539.1 |
|
|
645.6 |
|
|
767.4 |
|
| Gross medical claims payable, end of period |
|
$ |
7,969.5 |
|
|
$ |
7,498.6 |
|
|
$ |
7,892.6 |
|
|
$ |
7,569.8 |
|
|
$ |
6,861.2 |
|
|
|
|
|
|
|
|
|
|
|
|
| Current year medical claims paid as a percentage of current year net incurred medical
claims |
|
80.0 |
% |
|
80.7 |
% |
|
89.1 |
% |
|
89.1 |
% |
|
89.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
| Prior year redundancies in the current year as a percentage of prior year net medical
claims payable less prior year redundancies in the current year |
|
14.9 |
% |
|
11.7 |
% |
|
14.0 |
% |
|
15.1 |
% |
|
9.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
| Prior year redundancies in the current year as a percentage of prior year net
incurred medical claims |
|
1.5 |
% |
|
1.2 |
% |
|
1.4 |
% |
|
1.4 |
% |
|
1.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
(1) Negative amounts reported for net incurred medical claims related to prior years
result from claims being settled for amounts less than originally estimated.
|
|
Anthem, Inc.
|
|
GAAP Reconciliation
|
| (Unaudited) |
| |
| Anthem, Inc. has referenced “Adjusted Net Income” and “Adjusted Net Income Per
Share,” which are non-GAAP measures, in this document. These non-GAAP measures are not intended to be alternatives to any
measure calculated in accordance with GAAP. In addition to these non-GAAP measures, references are made to the measures
“Operating Revenue” and “Operating Gain.” Each of these measures is provided to further aid investors in understanding and
analyzing the company’s core operating results and comparing Anthem, Inc.’s financial results. A reconciliation of Operating
Revenue to Total Revenue is set forth in the Consolidated Statements of Income herein. A reconciliation of the non-GAAP
measures to the most directly comparable measures calculated in accordance with GAAP, together with a reconciliation of
reportable segments operating gain to income before income tax expense, is reported below. |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
Six Months Ended |
|
|
|
|
June 30 |
|
|
|
June 30 |
|
|
| (In millions, except per share data) |
|
2017 |
|
2016 |
|
Change |
|
2017 |
|
2016 |
|
Change |
| Net income |
|
$ |
855.3 |
|
|
$ |
780.6 |
|
|
9.6 |
% |
|
$ |
1,865.2 |
|
|
$ |
1,483.6 |
|
|
25.7 |
% |
| Add / (Subtract): |
|
|
|
|
|
|
|
|
|
|
|
|
| Net realized (gains)/losses on financial instruments |
|
(16.2 |
) |
|
(12.5 |
) |
|
|
|
(23.5 |
) |
|
112.6 |
|
|
|
| Other-than-temporary impairment losses recognized in income |
|
7.2 |
|
|
25.7 |
|
|
|
|
15.3 |
|
|
92.6 |
|
|
|
| Transaction related costs |
|
51.2 |
|
|
79.2 |
|
|
|
|
150.9 |
|
|
174.7 |
|
|
|
| Income tax true-up of prior transaction costs |
|
(69.3 |
) |
|
— |
|
|
|
|
(69.3 |
) |
|
— |
|
|
|
| 2015 cyber attack litigation settlement |
|
115.0 |
|
|
— |
|
|
|
|
115.0 |
|
|
— |
|
|
|
| Amortization of other intangible assets |
|
40.6 |
|
|
47.9 |
|
|
|
|
82.4 |
|
|
98.3 |
|
|
|
| Penn Treaty assessment costs |
|
— |
|
|
— |
|
|
|
|
253.8 |
|
|
— |
|
|
|
| Deferred tax asset write-off from California tax legislation |
|
— |
|
|
20.7 |
|
|
|
|
— |
|
|
20.7 |
|
|
|
| Tax impact of non-GAAP adjustments |
|
(71.4 |
) |
|
(48.2 |
) |
|
|
|
(212.0 |
) |
|
(164.0 |
) |
|
|
| Net adjustment items |
|
57.1 |
|
|
112.8 |
|
|
|
|
312.6 |
|
|
334.9 |
|
|
|
| Adjusted net income |
|
$ |
912.4 |
|
|
$ |
893.4 |
|
|
2.1 |
% |
|
$ |
2,177.8 |
|
|
$ |
1,818.5 |
|
|
19.8 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net income per diluted share |
|
$ |
3.16 |
|
|
$ |
2.91 |
|
|
8.6 |
% |
|
$ |
6.89 |
|
|
$ |
5.54 |
|
|
24.4 |
% |
| Add / (Subtract): |
|
|
|
|
|
|
|
|
|
|
|
|
| Net realized (gains)/losses on financial instruments |
|
(0.06 |
) |
|
(0.05 |
) |
|
|
|
(0.09 |
) |
|
0.42 |
|
|
|
| Other-than-temporary impairment losses recognized in income |
|
0.03 |
|
|
0.10 |
|
|
|
|
0.06 |
|
|
0.35 |
|
|
|
| Transaction related costs |
|
0.19 |
|
|
0.30 |
|
|
|
|
0.56 |
|
|
0.65 |
|
|
|
| Income tax true-up of prior transaction costs |
|
(0.26 |
) |
|
— |
|
|
|
|
(0.26 |
) |
|
— |
|
|
|
| 2015 cyber attack litigation settlement |
|
0.42 |
|
|
— |
|
|
|
|
0.42 |
|
|
— |
|
|
|
| Amortization of other intangible assets |
|
0.15 |
|
|
0.18 |
|
|
|
|
0.30 |
|
|
0.37 |
|
|
|
| Penn Treaty assessment costs |
|
— |
|
|
— |
|
|
|
|
0.94 |
|
|
— |
|
|
|
| Deferred tax asset write-off from California tax legislation |
|
— |
|
|
0.08 |
|
|
|
|
— |
|
|
0.08 |
|
|
|
| Tax impact of non-GAAP adjustments |
|
(0.26 |
) |
|
(0.18 |
) |
|
|
|
(0.78 |
) |
|
(0.61 |
) |
|
|
| Rounding Impact |
|
— |
|
|
(0.01 |
) |
|
|
|
0.01 |
|
|
(0.01 |
) |
|
|
| Net adjustment items |
|
0.21 |
|
|
0.42 |
|
|
|
|
1.16 |
|
|
1.25 |
|
|
|
| Adjusted net income per diluted share |
|
$ |
3.37 |
|
|
$ |
3.33 |
|
|
1.2 |
% |
|
$ |
8.05 |
|
|
$ |
6.79 |
|
|
18.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Full Year 2017 |
|
|
|
|
|
|
|
|
|
|
Outlook |
|
|
|
|
|
|
|
|
| Net income per diluted share |
|
Greater than $10.35 |
|
|
|
|
|
|
|
|
| Add / (Subtract): |
|
|
|
|
|
|
|
|
|
|
| Net realized (gains)/losses on financial instruments |
|
(0.09 |
) |
|
|
|
|
|
|
|
|
| Other-than-temporary impairment losses recognized in income |
|
0.06 |
|
|
|
|
|
|
|
|
|
| Transaction related costs |
|
0.56 |
|
|
|
|
|
|
|
|
|
| Income tax true-up of prior transaction costs |
|
(0.26 |
) |
|
|
|
|
|
|
|
|
| 2015 cyber attack litigation settlement |
|
0.42 |
|
|
|
|
|
|
|
|
|
| Penn Treaty assessment costs |
|
0.94 |
|
|
|
|
|
|
|
|
|
| Amortization of other intangible assets |
|
Approximately $0.60 |
|
|
|
|
|
|
|
|
| Tax impact of non-GAAP adjustments |
|
Approximately ($0.88) |
|
|
|
|
|
|
|
|
| Net adjustment items |
|
Approximately $1.35 |
|
|
|
|
|
|
|
|
| Adjusted net income per diluted share |
|
Greater than $11.70 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
Six Months Ended |
|
|
|
|
June 30 |
|
|
|
June 30 |
|
|
| (In millions) |
|
2017 |
|
2016 |
|
Change |
|
2017 |
|
2016 |
|
Change |
| Reportable segments operating gain |
|
$ |
1,227.0 |
|
|
$ |
1,500.2 |
|
|
(18.2 |
)% |
|
$ |
2,812.4 |
|
|
$ |
3,070.6 |
|
|
(8.4 |
)% |
| Net investment income |
|
200.2 |
|
|
194.9 |
|
|
|
|
407.4 |
|
|
366.0 |
|
|
|
| Net realized gains/(losses) on financial instruments |
|
16.2 |
|
|
12.5 |
|
|
|
|
23.5 |
|
|
(112.6 |
) |
|
|
| Other-than-temporary impairment losses recognized in income |
|
(7.2 |
) |
|
(25.7 |
) |
|
|
|
(15.3 |
) |
|
(92.6 |
) |
|
|
| Interest expense |
|
(189.9 |
) |
|
(185.7 |
) |
|
|
|
(424.9 |
) |
|
(372.8 |
) |
|
|
| Amortization of other intangible assets |
|
(40.6 |
) |
|
(47.9 |
) |
|
|
|
(82.4 |
) |
|
(98.3 |
) |
|
|
| Income from continuing operations before income tax expense |
|
$ |
1,205.7 |
|
|
$ |
1,448.3 |
|
|
(16.8 |
)% |
|
$ |
2,720.7 |
|
|
$ |
2,760.3 |
|
|
(1.4 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward-Looking Statements
This document contains certain forward-looking information about us that is intended to be covered by the safe harbor for
“forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are
generally not historical facts. Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,” “intend,”
“estimate,” “project,” “forecast,” “plan” and similar expressions are intended to identify forward-looking statements. These
statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements
regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding
future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and
generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected
by, the forward-looking statements. These risks and uncertainties include: those discussed and identified in our public filings
with the U.S. Securities and Exchange Commission, or SEC; increased government participation in, or regulation or taxation of
health benefits and managed care operations, including, but not limited to, the impact of the Patient Protection and Affordable
Care Act and the Health Care and Education Reconciliation Act of 2010, or Health Care Reform, and the impact of any future
modification, repeal or replacement of Health Care Reform; trends in health care costs and utilization rates; our ability to secure
sufficient premium rates including regulatory approval for and implementation of such rates; our participation in federal and state
health insurance exchanges under Health Care Reform, which have experienced and continue to experience challenges due to
implementation of initial and phased-in provisions of Health Care Reform, and which entail uncertainties associated with the mix
and volume of business, particularly in our Individual and Small Group markets, that could negatively impact the adequacy of our
premium rates and which may not be sufficiently offset by the risk apportionment provisions of Health Care Reform; the ultimate
outcome of litigation between Cigna Corporation (“Cigna”) and us related to the merger agreement between the parties, including our
claim for damages against Cigna, Cigna’s claim for payment of a termination fee and other damages against us, and the potential for
such litigation to cause us to incur substantial costs, materially distract management and negatively impact our reputation and
financial positions; our ability to contract with providers on cost-effective and competitive terms; competitor pricing below
market trends of increasing costs; reduced enrollment, as well as a negative change in our health care product mix; risks and
uncertainties regarding Medicare and Medicaid programs, including those related to non-compliance with the complex regulations
imposed thereon and funding risks with respect to revenue received from participation therein; a downgrade in our financial
strength ratings; increases in costs and other liabilities associated with increased litigation, government investigations, audits
or reviews; medical malpractice or professional liability claims or other risks related to health care services provided by our
subsidiaries; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our
cash flow and earnings and other considerations; non-compliance by any party with the Express Scripts, Inc. pharmacy benefit
management services agreement, which could result in financial penalties; our inability to meet customer demands, and sanctions
imposed by governmental entities, including the Centers for Medicare and Medicaid Services; events that result in negative
publicity for us or the health benefits industry; failure to effectively maintain and modernize our information systems; events
that may negatively affect our licenses with the Blue Cross and Blue Shield Association; state guaranty fund assessments for
insolvent insurers; possible impairment of the value of our intangible assets if future results do not adequately support goodwill
and other intangible assets; intense competition to attract and retain employees; unauthorized disclosure of member or employee
sensitive or confidential information, including the impact and outcome of investigations, inquiries, claims and litigation related
to the cyber attack we reported in February 2015; changes in economic and market conditions, as well as regulations that may
negatively affect our investment portfolios and liquidity; possible restrictions in the payment of dividends by our subsidiaries
and increases in required minimum levels of capital and the potential negative effect from our substantial amount of outstanding
indebtedness; general risks associated with mergers, acquisitions and strategic alliances; various laws and provisions in our
governing documents that may prevent or discourage takeovers and business combinations; future public health epidemics and
catastrophes; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements
that speak only as of the date hereof. We do not undertake to update or revise any forward-looking statements, except as required
by applicable securities laws. Investors are also advised to carefully review and consider the various risks and other disclosures
discussed in our SEC reports.
Anthem Contacts:
Investor Relations
Will Feest, 317-488-6057
William.feest@anthem.com
or
Media
Jill Becher, 414-234-1573
Jill.becher@anthem.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170726005341/en/